Misapprehension in patients prescribed palliative chemotherapy for metastatic cancer
Many patients who are prescribed palliative chemotherapy for metastatic cancer misconstrue the possible effects of such treatment.
The level of misapprehension is high, many patients overestimate the benefits with some even presuming curative intent. In part, this misunderstanding may derive from the patient's distressed state precluding conscious attentiveness when the details are discussed and consent for treatment obtained.
However, it might also result from poor clinician communication and their non-disclosure of the full details relevant to the patient. The availability and suitability of printed or other resources to support this process may also further the misconceptions.
This American study describes the experience of developing and appraising stakeholder involvement to instruct the patient centred informed consent process for palliative care chemotherapy interventions.
A multiprofessional expert team undertook an iterative process of design of new video and printed paper based
...Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
This article is not available as part of an institutional subscription. Why is this?
